Parabolic Drugs Ltd. - Research Center
533211 PARABDRUGS Group (Z) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 20 | Mar ' 18 | Mar ' 17 | Mar ' 16 | Mar ' 15 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | - | 72.60 | 73.72 | 75.60 | 231.78 |
| Expenses | |||||
| Material consumed | - | 63.49 | 91.95 | 328.52 | 255.84 |
| Manufacturing expenses | - | - | - | - | 15.26 |
| Personnel expenses | 1.68 | 9.30 | 8.47 | 10.68 | 17.01 |
| Selling expenses | - | 0.03 | 0.04 | 0.04 | - |
| Adminstrative expenses | 4.73 | 16.24 | 19.15 | 42.75 | 22.26 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 6.41 | 89.06 | 119.60 | 381.98 | 310.36 |
| Operating profit | - | -16.46 | -45.88 | -306.39 | -78.58 |
| Other recurring income | 0.02 | 4.11 | 4.25 | 0.31 | 1.24 |
| Adjusted PBDIT | -6.39 | -12.36 | -41.62 | -306.08 | -77.34 |
| Financial expenses | 0.66 | 8.35 | 9.91 | 107.62 | 98.69 |
| Depreciation | 21.59 | 34.54 | 53.49 | 67.06 | 72.97 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | -28.64 | -55.24 | -105.02 | -480.76 | -249.00 |
| Tax charges | - | 1.76 | 3.05 | 4.43 | 130.33 |
| Adjusted PAT | - | -57.00 | -108.07 | -485.19 | -379.32 |
| Non recurring items | - | - | - | - | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | -28.64 | -57.00 | -108.07 | -485.19 | -379.32 |
| Earnigs before appropriation | -28.64 | -1,097.67 | -1,040.67 | -932.60 | -447.75 |
| Equity dividend | - | - | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | -28.64 | -1,097.67 | -1,040.67 | -932.60 | -447.75 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis